REGISTERED NUMBER: 12523244 (England and Wales)

Unaudited Financial Statements

for the Year Ended 31 March 2026

for

DPCLINIC LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

T Jones

D Popelyuk

REGISTERED OFFICE:

5 Giffard Court

Millbrook Close

Northampton

NN5 5JF

REGISTERED NUMBER:

12523244 (England and Wales)

ACCOUNTANTS:

Sandison Lang Limited

2 St Marys Road

Tonbridge

Kent

TN9 2LB

FIXED ASSETS

Property, plant and equipment

4

46,516

40,772

Investments

5

2,322,715

1,654,737

2,369,231

1,695,509

CURRENT ASSETS

Cash at bank

710,968

234,564

CREDITORS

Amounts falling due within one year

6

(155,463

)

(4,776

)

NET CURRENT ASSETS

555,505

229,788

TOTAL ASSETS LESS CURRENT LIABILITIES

2,924,736

1,925,297

CAPITAL AND RESERVES

Called up share capital

100

100

Retained earnings

2,924,636

1,925,197

2,924,736

1,925,297

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17 July 2026 and were signed on its behalf by:

D Popelyuk - Director

1.	STATUTORY INFORMATION

Dpclinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover

Revenue is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery

-

25% on reducing balance

Fixtures and fittings

-

25% on reducing balance

Computer equipment

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 9 (2025 - 8 ) .

4.	PROPERTY, PLANT AND EQUIPMENT

Plant and

machinery

etc

£

COST

At 1 April 2025

89,246

Additions

19,857

At 31 March 2026

109,103

DEPRECIATION

At 1 April 2025

48,474

Charge for year

14,113

At 31 March 2026

62,587

NET BOOK VALUE

At 31 March 2026

46,516

At 31 March 2025

40,772

5.	FIXED ASSET INVESTMENTS

Other

investments

£

COST OR VALUATION

At 1 April 2025

1,654,737

Additions

359,999

Revaluations

289,800

Exchange differences

(13,467

)

Dividends received

31,646

At 31 March 2026

2,322,715

NET BOOK VALUE

At 31 March 2026

2,322,715

At 31 March 2025

1,654,737

Cost or valuation at 31 March 2026 is represented by:

Other

investments

£

Valuation in 2026

2,322,715

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Tax

137,526

-

Social security and other taxes

(1

)

2

Pension control

745

764

Credit Card Control

15,503

2,713

Directors' current accounts

544

223

Accrued expenses

1,146

1,074

155,463

4,776